Patient info Open main menu

Glucophage SR 1000 mg prolonged-release tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
1000 mg
Contains active substance:
ATC code:
Similar medicines:

Patient leaflet - Glucophage SR 1000 mg prolonged-release tablets

1. What Glucophage SR is and what it is used for

Glucophage SR prolonged release tablets contain the active ingredient metformin hydrochloride and belong to a group of medicines called biguanides, used in the treatment of Type 2 (non-insulin dependent) diabetes mellitus.

Glucophage SR is used together with diet and exercise to lower the risk of developing Type 2 diabetes in overweight adults, when diet and exercise alone for 3 to 6 months have not been enough to control blood glucose (sugar). You are at high risk of developing Type 2 diabetes if you have additional conditions like high blood pressure, age above 40 years, an abnormal amount of lipids (fat) in the blood or a history of diabetes during pregnancy.

The medicine is particularly effective if you are aged below 45 years, are very overweight, have high blood glucose levels after a meal or developed diabetes during pregnancy.

Glucophage SR is used for the treatment of Type 2 diabetes when diet and exercise changes alone have not been enough to control blood glucose (sugar). Insulin is a hormone that enables body tissues to take glucose from the blood and to use it for energy or for storage for future use. People with Type 2 diabetes do not make enough insulin in their pancreas or their body does not respond properly to the insulin it does

make. This causes a build-up of glucose in the blood which can cause a number of serious long-term problems so it is important that you continue to take your medicine, even though you may not have any obvious symptoms. Glucophage SR makes the body more sensitive to insulin and helps return to normal the way your body uses glucose.

Glucophage SR is associated with either a stable body weight or modest weight loss.

Glucophage SR Prolonged Release Tablets are specially made to release the drug slowly in your body and therefore are different to many other types of tablet containing metformin.

Polycystic ovary syndrome (PCOS) is a health condition that affects a woman's hormone levels, menstrual cycle, and ability to have children. Glucophage SR is used in women with PCOS to stimulate ovulation (release of an egg from the ovaries), and subsequently the chance of getting pregnant, alone or together with other treatment options.

2. What you need to know before you take Glucophage SR

Do not take Glucophage SR if:

  • you are allergic to metformin or to any of the other ingredients of this medicine (listed in section 6). An allergic reaction may cause a rash, itching or shortness of breath.
  • you have liver problems
  • you have severely reduced kidney function
  • you have uncontrolled diabetes, with, for example, severe hyperglycaemia (high blood glucose), nausea, vomiting, diarrhoea, rapid weight loss, lactic acidosis (see ‘Risk of lactic acidosis’ below) or ketoacidosis. Ketoacidosis is a condition in which substances called ‘ketone bodies’ accumulate in the blood and which can lead to diabetic pre-coma. Symptoms include stomach pain, fast and deep breathing, sleepiness or your breath developing an unusual, fruity smell.
  • you have lost too much water from your body (dehydration). Dehydration may lead to kidney problems, which can put you at risk for lactic acidosis (see 'Warnings and precautions').
  • you have a severe infection, such as an infection affecting your lung or bronchial system or your kidney. Severe infections may lead to kidney problems, which can put you at risk for lactic acidosis (see 'Warnings and precautions').

    • you have been treated for acute heart problems or have recently had a heart attack or have severe circulatory problems or breathing difficulties. This may lead to a lack in oxygen supply to tissue which can put you at risk for lactic acidosis (see 'Warnings and precautions').
    • you are a heavy drinker of alcohol.
    • you are under 18 years of age.

Warnings and precautions

Risk of lactic acidosis.

Glucophage SR may cause a very rare, but very serious side effect called lactic acidosis, particularly if your kidneys are not working properly. The risk of developing lactic acidosis is also increased with uncontrolled diabetes, serious infections, prolonged fasting or alcohol intake, dehydration (see further information below), liver problems and any medical conditions in which a part of the body has a reduced supply of oxygen (such as acute severe heart disease).

If any of the above apply to you, talk to your doctor for further instructions.

Stop taking Glucophage SR for a short time if you have a condition that may be associated with dehydration

(significant loss of body fluids) such as severe vomiting, diarrhoea, fever, exposure to heat or if you drink less fluid than normal. Talk to your doctor for further instructions.

Stop taking Glucophage SR and contact a doctor or the nearest hospital immediately if you experience some of the symptoms of lactic acidosis, as this condition may lead to coma.

Symptoms of lactic acidosis include:

  • vomiting
  • stomach ache (abdominal pain)
  • muscle cramps
  • a general feeling of not being well with severe tiredness
  • difficulty in breathing
  • reduced body temperature and heartbeat

Lactic acidosis is a medical emergency and must be treated in a hospital.

Talk to your doctor promptly for further instructions if:

  • You are known to suffer from a genetically inherited disease affecting mitochondria (the energy-producing components within cells) such as MELAS syndrome (Mitochondrial Encephalopathy, myopathy, Lactic acidosis and Stroke-like episodes) or Maternal inherited diabetes and deafness (MlDD).
  • You have any of these symptoms after starting metformin: seizure, declined cognitive abilities, difficulty with body movements, symptoms indicating nerve damage (e.g. pain or numbness), migraine and deafness.

If you need to have major surgery you must stop taking Glucophage SR during and for some time after the procedure. Your doctor will decide when you must stop and when to restart your treatment with Glucophage SR.

During treatment with Glucophage SR, your doctor will check your kidney function at least once a year or more frequently if you are elderly and/or if you have worsening kidney function.

If you are older than 75 years, treatment with Glucophage SR should not be started to lower the risk of developing type 2 diabetes.

You may see some remains of the tablets in your stools. Do not worry- this is normal for this type of tablet.

You should continue to follow any dietary advice that your doctor has given you and you should make sure that you eat carbohydrates regularly throughout the day.

Do not stop taking this medicine without speaking to your doctor.

Other medicines and Glucophage SR

If you need to have an injection of a contrast medium that contains iodine into your bloodstream, for example in the context of an X-ray or scan, you must stop taking Glucophage SR before or at the time of injection. Your doctor will decide when you must stop and when to restart your treatment with Glucophage SR.

Tell your doctor if you are taking, have recently taken or might take any other medicines. You may need more frequent blood glucose and kidney function tests, or your doctor may need to adjust the dosage of Glucophage SR. It is especially important to mention the following:

  • Medicines which increase urine production (diuretics (water tablets) such as furosemide).
  • Medicines used to treat pain and inflammation (NSAID and COX-2 inhibitors, such as ibuprofen and celecoxib)
  • Certain medicines for the treatment of high blood pressure (ACE inhibitors and angiotensin II receptor antagonists)
  • Steroids such as prednisolone, mometasone, beclometasone.
  • Sympathomimetic medicines including epinephrine and dopamine used to treat heart attacks and low blood pressure. Epinephrine is also included in some dental anaesthetics.
  • Medicines that may change the amount of Glucophage SR in your blood, especially if you have reduced kidney function (such as verapamil, rifampicin, cimetidine, dolutegravir, ranolazine, trimethoprim, vandetanib, isavuconazole, crizotinib, olaparib).

Glucophage SR with alcohol:

Avoid excessive alcohol intake while taking Glucophage SR since this may increase the risk of lactic acidosis (see section ‘Warnings and precautions’).

Pregnancy and breast-feeding

If you are pregnant, think you may be pregnant or are planning to have a baby, speak to your doctor in case any changes will be needed to your treatment or monitoring of your blood glucose levels.

This medicine is not recommended if you are breast-feeding or if you are planning to breast-feed your baby.

Women of childbearing potential:

Glucophage SR can stimulate ovulation (release of an egg from the ovaries), in women who do not ovulate properly.

Beware of an increased chance of becoming pregnant when using Glucophage SR.

Driving and using machines

Glucophage SR taken on its own does not cause ‘hypos’ (symptoms of low blood sugar or hypoglycaemia, such as faintness, confusion and increased sweating) and therefore should not affect your ability to drive or use machinery.

You should be aware, however, that Glucophage SR taken with other antidiabetic medicines can cause hypos, so in this case you should take extra care when driving or operating machinery.

Information about ingredient of Glucophage SR

This medicine contains less than 1mmol sodium (23mg) per dosage unit, that is to say it is essentially ‘sodium free’.

3. How to take Glucophage SR

Your doctor may prescribe Glucophage SR for you to take on its own or in combination with other oral antidiabetic medicines or insulin.

Always take this medicine exactly as your doctor has told you.

You should check with your doctor or pharmacist if you are not sure.

Swallow the tablets whole with a glass of water, do not chew.

Recommended dose

Usually you will start treatment with 500 milligrams Glucophage SR daily. After you have been taking Glucophage SR for about 2 weeks, your doctor may measure your blood sugar and adjust the dose. The maximum daily dose is 2000 milligrams of Glucophage SR.

If you have reduced kidney function, your doctor may prescribe a lower dose.

Normally, you should take the tablets once a day, with your evening meal.

In some cases, your doctor may recommend that you take the tablets twice a day. Always take the tablets with food.

Polycystic ovary syndrome (PCOS)

The usual dose is 1500-2000 mg metformin hydrochloride taken once a day with the evening meal. You should check with your doctor or pharmacist when to stop taking the medicine.

If you take more Glucophage SR than you should

If you take extra tablets by mistake you need not worry, but if you have unusual symptoms, contact your doctor. If the overdose is large, lactic acidosis is more likely. Symptoms of lactic acidosis are non-specific, such as vomiting, bellyache with muscle cramps, a general feeling of not being well with severe tiredness, and difficulty in breathing. Further symptoms are reduced body temperature and heart beat. If you experience some of these symptoms, you should immediately seek

medical attention, as lactic acidosis may lead to coma. Stop taking Glucophage SR immediately and contact a doctor or the nearest hospital straightaway.

If you forget to take Glucophage SR

Take it as soon as you remember with some food. Do not take a double dose to make up for a forgotten dose.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may occur:

Glucophage SR may cause a very rare (may affect up to 1 user in

10,000) but very serious side effect called lactic acidosis (see section ‘Warnings and precautions’). If this happens, you must stop taking the Glucophage SR and contact a doctor or the nearest hospital immediately, as lactic acidosis may lead to coma.

Glucophage SR may cause abnormal liver function tests and hepatitis

(inflammation of the liver) which may result in jaundice (may affect up to 1 user in 10,000). If you develop yellowing of the eyes and/or skin contact your doctor immediately.

Other possible side effects are listed by frequency as follows:

Very common side effects (may affect more than 1 in 10 people):

  • Diarrhoea, nausea, vomiting, stomach ache or loss of appetite. If you get these, do not stop taking the tablets as these symptoms will normally go away in about 2 weeks. It helps if you take the tablets with or immediately after a meal.

Common side effects (may affect up to 1 in 10 people):

  • Taste disturbance
  • decreased or low vitamin B12 levels in the blood (symptoms may include extreme tiredness (fatigue), a sore and red tongue (glossitis), pins and needles (paraesthesia) or pale or yellow skin). Your doctor may arrange some tests to find out the cause of your symptoms because some of these may also be caused by diabetes or due to other unrelated health problems.

Very rare side effects (may affect up to 1 in 10,000 people):

  • Skin rashes including redness, itching and hives.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist.

This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Glucophage SR

Keep out of the sight and reach of children.

Do not use this medicine after the expiry date that is printed on the pack after “Expiry”. The expiry date refers to the last day of that month.

Store in the original package in order to protect from light and moisture

If the tablets become discoloured or show any other signs of deterioration seek the advice of your pharmacist who will tell you what to do.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information

What the tablets contain

Each prolonged release tablet contains 1000 mg metformin hydrochloride equivalent to 780 mg metformin.

Also includes magnesium stearate, carmellose sodium, hypromellose 100 000 cPs and purified water.

What Glucophage SR looks like and contents of the pack

White, biconvex capsule-shaped tablets marked ‘1000’ on one side, plain on the other side.

Available in blister packs of 30 prolonged release tablets.

Who manufactured your medicine

Manufactured by Special Product’s Line SpA, via Fratta Rotonda Vado Largo 1, 03012 Anagni, Italy.

or

Savio Industrial S.r.l., Via Emilia, 21-27100 Pavia, Italy. Procured from within the EU and repackaged by Product Licence holder Uni Health Distribution Ltd, Unit G4 Riverside Industrial Estate, Riverside Way, Dartford, Kent, DA1 5BS.

PL 45396/0253 POM

Leaflet date: 11 August 2025 Ref: Glu15/UT2

Glucophage is a registered trademark of Merck Sante.

Blind or partially sighted?

Is this leaflet hard to see or read?

Call 01322 629220 to obtain the leaflet in a format suitable for you

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 45396/0253

Last revision stated in the text: 11 August 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Glucophage SR 1000 mg prolonged-release tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Metformin
Strength 1000 mg
Pharmaceutical form Modified-release tablet
How is it taken Oral
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. A Alimentary tract and metabolism drugs
    1. A10 Drugs used in diabetes
      1. A10B Blood glucose lowering drugs, excl. insulins
        1. A10BA Biguanide blood glucose lower drugs
          1. A10BA02 metformin
Marketing authorisation PLPI 45396/0253
Codes BNF 06010202

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.